FDA
Mississippi AG Fitch Calls on National Security Council to Safeguard GLP-1 Drug Supply Chain from Chinese Exploitation
Attorney General Lynn Fitch joins 19 other state attorneys general in urging the administration to protect against Chinese efforts to introduce unsafe pharmaceutical ingredients into the U.S. market, citing recent violations of FDA safeguards for popul...
South Korea to Introduce Medication Abortion Pills as Early as First Quarter 2025
Government announces plan to approve mifepristone for pregnancies up to nine weeks, with doctors to dispense directly for two years. Medical and religious groups raise concerns over incomplete legal framework....
General Mills completa la eliminación de colorantes artificiales de todos sus cereales en EE.UU.
La compañía de alimentos cumplió con anticipación su compromiso de eliminar tintes sintéticos de productos como Lucky Charms y Trix, utilizando ahora colorantes naturales derivados de frutas, verduras y especias....
Antengene's ATG-201 Autoimmune Therapy Receives Australian Clinical Trial Approval
Biotech company Antengene has secured regulatory clearance in Australia to begin Phase I trials of ATG-201, a bispecific antibody targeting B cell-related autoimmune diseases, marking the therapy's expansion beyond China into international markets....
Rosen Law Firm Announces Class Action Lawsuit Against Aardvark Therapeutics Over Drug Safety Disclosures
Law firm Rosen announces securities class action against Aardvark Therapeutics following FDA clinical hold on lead drug candidate ARD-101, with investors facing an October 13, 2026 deadline to seek lead plaintiff status....
